Fenofibrate Augments the Sensitivity of Drug-Resistant Prostate Cancer Cells to Docetaxel
出版年份 2019 全文链接
标题
Fenofibrate Augments the Sensitivity of Drug-Resistant Prostate Cancer Cells to Docetaxel
作者
关键词
-
出版物
Cancers
Volume 11, Issue 1, Pages 77
出版商
MDPI AG
发表日期
2019-01-11
DOI
10.3390/cancers11010077
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Fenofibrate inhibits mTOR-p70S6K signaling and simultaneously induces cell death in human prostate cancer cells
- (2018) Xin Lian et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- mi R -27b and mi R -34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1
- (2018) Guangwei Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Role of PPAR-α agonist fenofibrate in the treatment of induced benign prostatic hyperplasia with dysplastic changes in rats
- (2018) Marwa M.M. Refaie et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- The Dualistic Origin of Human Tumors
- (2018) Jinsong Liu SEMINARS IN CANCER BIOLOGY
- Anticancer Properties of Fenofibrate: A Repurposing Use
- (2018) Xin Lian et al. Journal of Cancer
- Fenofibrate inhibits the growth of prostate cancer through regulating autophagy and endoplasmic reticulum stress
- (2018) Tao Tao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Fenofibrate Interferes with the Diapedesis of Lung Adenocarcinoma Cells through the Interference with Cx43/EGF-Dependent Intercellular Signaling
- (2018) Katarzyna Piwowarczyk et al. Cancers
- Connexin43 high prostate cancer cells induce endothelial connexin43 up-regulation through the activation of intercellular ERK1/2-dependent signaling axis
- (2017) Katarzyna Piwowarczyk et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer
- (2017) Karen Hanrahan et al. Molecular Oncology
- Novel strategies to prevent the development of multidrug resistance (MDR) in cancer
- (2017) Jinglu Wang et al. Oncotarget
- Multidrug-resistant cancer cells and cancer stem cells hijack cellular systems to circumvent systemic therapies, can natural products reverse this?
- (2016) Qian Zhang et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells
- (2016) Kyle McIntosh et al. Expert Opinion on Drug Metabolism & Toxicology
- Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells
- (2016) Luigi Ippolito et al. Oncotarget
- Sensitization to docetaxel in prostate cancer cells by green tea and quercetin
- (2015) Piwen Wang et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Functional links between Snail-1 and Cx43 account for the recruitment of Cx43-positive cells into the invasive front of prostate cancer
- (2014) Damian Ryszawy et al. CARCINOGENESIS
- Fenofibrate enhances barrier function of endothelial continuum within the metastatic niche of prostate cancer cells
- (2014) Katarzyna Piwowarczyk et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Cancer stem cells and tumor metastasis
- (2014) SHUANG LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Molecular Mechanisms of Fenofibrate-Induced Metabolic Catastrophe and Glioblastoma Cell Death
- (2014) Anna Wilk et al. MOLECULAR AND CELLULAR BIOLOGY
- Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer
- (2014) M. Marin-Aguilera et al. MOLECULAR CANCER THERAPEUTICS
- Triterpene saponosides from Lysimachia ciliata differentially attenuate invasive potential of prostate cancer cells
- (2013) Paulina Koczurkiewicz et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Peroxisome Proliferator Activated Receptor α Ligands as Anticancer Drugs Targeting Mitochondrial Metabolism
- (2013) Maja Grabacka et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer
- (2013) Nathan J. Robison et al. PEDIATRIC BLOOD & CANCER
- The roots of cancer: Stem cells and the basis for tumor heterogeneity
- (2012) Maho Shibata et al. BIOESSAYS
- EMT and MET in Metastasis: Where Are the Cancer Stem Cells?
- (2012) Thomas Brabletz CANCER CELL
- Fenofibrate triggers apoptosis of glioblastoma cells in vitro
- (2012) Antonio Giordano et al. CELL CYCLE
- ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARα -mediated inhibition of Glioma cell motility in vitro
- (2012) Justyna Drukala et al. Molecular Cancer
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Exploring cancer stem cell niche directed tumor growth
- (2011) Andrea Sottoriva et al. CELL CYCLE
- Fenofibrate
- (2011) Kate McKeage et al. DRUGS
- Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPARα-independent mechanisms
- (2011) Daisuke Yamasaki et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Cells of origin in cancer
- (2011) Jane E. Visvader NATURE
- Cancer invasion and resistance: interconnected processes of disease progression and therapy failure
- (2011) Stephanie Alexander et al. TRENDS IN MOLECULAR MEDICINE
- On the Stem Cell Origin of Cancer
- (2010) Stewart Sell AMERICAN JOURNAL OF PATHOLOGY
- Gap junctions and connexins as therapeutic targets in cancer
- (2010) Mustapha Kandouz et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Cancer stem cells: problems for therapy?
- (2010) Malcolm R Alison et al. JOURNAL OF PATHOLOGY
- Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFα/NF-κB signaling axis
- (2010) Z Zak et al. LEUKEMIA
- Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
- (2009) Mark Shackleton et al. CELL
- Non-genetic heterogeneity — a mutation-independent driving force for the somatic evolution of tumours
- (2009) Amy Brock et al. NATURE REVIEWS GENETICS
- Expression of multidrug resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs
- (2009) Catherine Sánchez et al. PROSTATE
- PPARs: A Double-Edged Sword in Cancer Therapy?
- (2009) Dipak Panigrahy et al. PPAR Research
- Prostate Cancer Stem Cells: A New Target for Therapy
- (2008) Norman J. Maitland et al. JOURNAL OF CLINICAL ONCOLOGY
- Prostate cancer stem cells
- (2008) SH Lang et al. JOURNAL OF PATHOLOGY
- PPAR agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition
- (2008) D. Panigrahy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anticancer Properties of PPARα-Effects on Cellular Metabolism and Inflammation
- (2008) Maja Grabacka et al. PPAR Research
- Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?
- (2008) Roberto Scatena et al. PPAR Research
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started